Monoclonal Antibodies Specific for Disease-Associated Point-Mutants: Lamin A/C R453W and R482W

• Marko Roblek ,

  Contributed equally to this work with: Marko Roblek, Stefan Schüchner

  Affiliation Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria

  ⨯
• Stefan Schüchner ,

  Contributed equally to this work with: Marko Roblek, Stefan Schüchner

  Affiliation Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria

  ⨯
• Veronika Huber,

  Affiliation Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria

  ⨯
• Katrin Ollram,

  Current address: Gregor Mendel Institute of Molecular Plant Biology, Vienna, Austria

  Affiliation Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria

  ⨯
• Sylvia Vlcek-Vesely,

  Current address: Institute of Molecular Pathology, Vienna, Austria

  Affiliation Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria

  ⨯
• Roland Foisner,

  Affiliation Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria

  ⨯
• Manfed Wehnert,

  Affiliation Institute of Human Genetics, Ernst-Moritz-Arndt-University, Greifswald, Germany

  ⨯
• Egon Ogris

  * E-mail: egon.ogris@meduniwien.ac.at

  Affiliation Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria

  ⨯